Cardiac Troponin I and T in ICI Myocarditis Screening, Diagnosis, and Prognosis
JACC CardioOncology,
Год журнала:
2024,
Номер
6(5), С. 804 - 807
Опубликована: Авг. 6, 2024
Язык: Английский
Multimodality Imaging and Immune‐Related Adverse Events During Immune Checkpoint Inhibitors Treatment: Where Do We Stand?
Echocardiography,
Год журнала:
2025,
Номер
42(3)
Опубликована: Март 1, 2025
Immune
checkpoint
inhibitors
(ICIs)
have
revolutionized
cancer
therapy,
significantly
improving
survival
across
various
malignancies.
However,
these
therapies
are
associated
with
types
of
immune-related
adverse
events
(irAEs),
including
cardiotoxicity,
a
spectrum
rare
but
potentially
life-threatening
complications
impacting
morbidity
and
mortality.
Cardiovascular
imaging
has
become
key
in
cardio-oncology,
providing
essential
diagnostic
tools
for
early
detection
monitoring.
This
review
synthesizes
current
evidence
underlines
the
pivotal
role
tailored
strategies
managing
ICI-induced
cardiotoxicity.
By
bridging
knowledge
gap,
it
aims
to
provide
targetable
insights
optimize
clinical
management
patients
undergoing
immunotherapy.
Язык: Английский
Predicting 30-Day Cardiotoxicity in Patients Receiving Immune Checkpoint Inhibitors: An Observational Study Utilizing XGBoost
Cardiovascular Toxicology,
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 10, 2025
Язык: Английский
Breast cancer and cardiovascular health
European Heart Journal,
Год журнала:
2024,
Номер
45(41), С. 4366 - 4382
Опубликована: Сен. 25, 2024
Abstract
Modern
cancer
therapies
greatly
improve
clinical
outcomes
for
both
early
and
advanced
breast
patients.
However,
these
advances
have
raised
concerns
about
potential
short-
long-term
toxicities,
including
cardiovascular
toxicities.
Therefore,
understanding
the
common
risk
factors
underlying
pathophysiological
mechanisms
contributing
to
toxicity
is
essential
ensure
best
outcomes.
While
cardio-oncology
has
emerged
as
a
sub-speciality
address
challenges,
it
that
all
cardiologists
recognize
understand
consequences
of
therapy.
This
review
aims
provide
comprehensive
overview
adverse
effects
associated
with
modern
therapies.
A
preventive,
diagnostic,
therapeutic
workflow
minimize
impact
on
patient
presented.
Key
aspects
this
include
regular
monitoring
function,
detection
management
therapy-related
optimization
factor
control.
By
highlighting
gaps
in
knowledge
some
areas,
emphasize
critical
role
research
ensuring
holistic
well-being
patients
cancer.
Язык: Английский
Insight of immune checkpoint inhibitor related myocarditis
International Immunopharmacology,
Год журнала:
2024,
Номер
143, С. 113559 - 113559
Опубликована: Ноя. 12, 2024
Язык: Английский
Management Status of Myocarditis-Related Sudden Cardiac Death
Reviews in Cardiovascular Medicine,
Год журнала:
2024,
Номер
25(12)
Опубликована: Дек. 23, 2024
Myocarditis,
a
life-threatening
disease
that
can
result
in
cardiac
arrest
and
sudden
death,
has
garnered
significant
attention
recent
years.
This
review
provides
comprehensive
overview
of
the
management
myocarditis-related
encompassing
its
pathology,
diagnostic
methods,
therapeutic
strategies,
preventive
measures,
prognostic
factors,
risk
stratification.
Additionally,
highlights
current
challenges
future
directions
this
field.
The
aim
is
to
enhance
understanding
death
inform
clinical
practice,
ultimately
leading
improved
patient
outcomes.
Язык: Английский